Kazutetsu Aoshiba Selected Research

Kazutetsu Aoshiba Research Topics

Disease

17	Inflammation (Inflammations) 03/2016 - 01/2003
12	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 08/2004
7	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2004
7	Pulmonary Emphysema 01/2017 - 03/2004
6	Fibrosis (Cirrhosis) 01/2018 - 08/2003
6	Emphysema 05/2015 - 02/2004
5	Neoplasms (Cancer) 10/2021 - 12/2004
5	Asthma (Bronchial Asthma) 10/2021 - 01/2003
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2021 - 08/2003
3	Acidosis 12/2020 - 11/2017
3	Pneumonia (Pneumonitis) 01/2018 - 08/2009
3	Lung Diseases (Lung Disease) 01/2016 - 08/2003
3	Wounds and Injuries (Trauma) 06/2011 - 06/2002
2	Dyspnea (Shortness of Breath) 01/2019 - 01/2015
2	Hemorrhage 03/2018 - 01/2015
2	Hypertrophy 11/2017 - 08/2004
2	Hyperplasia 10/2016 - 08/2004
2	Neoplasm Metastasis (Metastasis) 01/2016 - 03/2013
2	Airway Remodeling 05/2015 - 05/2014
1	Polymyositis 12/2021
1	Malignant Mesothelioma 10/2021
1	COVID-19 10/2021
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 10/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 10/2021
1	Hypoglycemia (Reactive Hypoglycemia) 10/2021
1	Infections 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Fever (Fevers) 01/2019
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Pulmonary Edema 03/2018
1	Hypercapnia 11/2017
1	Hypocapnia 11/2017
1	Secondary Hypertrophic Osteoarthropathy 01/2017
1	Bronchiolitis Obliterans Syndrome 10/2016
1	Tuberculosis (Tuberculoses) 07/2016

Drug/Important Bio-Agent (IBA)

6	Pancreatic Elastase (Elastase)IBA 01/2017 - 01/2006
5	Therapeutic UsesIBA 10/2021 - 03/2009
5	CytokinesIBA 10/2011 - 01/2003
4	SmokeIBA 10/2021 - 07/2006
4	Peptide Hydrolases (Proteases)FDA Link 10/2011 - 05/2006
3	SteroidsIBA 12/2021 - 06/2012
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2004
3	C-Reactive ProteinIBA 02/2020 - 05/2006
3	Oxidants (Oxidizing Agents)IBA 01/2019 - 06/2002
3	NF-kappa B (NF-kB)IBA 01/2010 - 01/2006
2	GlucocorticoidsIBA 10/2021 - 10/2021
2	Pharmaceutical PreparationsIBA 10/2021 - 06/2012
2	RoflumilastIBA 10/2021 - 06/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021 - 11/2017
2	LipidsIBA 07/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 02/2020 - 08/2003
2	naphthaleneIBA 10/2016 - 07/2014
2	MacrolidesIBA 03/2016 - 05/2014
2	Bromodeoxyuridine (BrdU)IBA 05/2015 - 06/2011
2	9- deoxy- 9- chloro- 15- deoxy- 16- hydroxy- 17,17- trimethylene- 19,20- didehydroprostaglandin E2IBA 08/2014 - 12/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 05/2014 - 04/2003
2	DNA (Deoxyribonucleic Acid)IBA 12/2013 - 06/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2013 - 08/2009
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2013 - 08/2003
2	Bronchodilator Agents (Bronchodilators)IBA 04/2013 - 06/2012
2	lecithinized superoxide dismutaseIBA 06/2012 - 09/2011
2	Superoxides (Superoxide)IBA 06/2012 - 09/2011
2	Protease Inhibitors (Protease Inhibitor)IBA 09/2011 - 04/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	OvalbuminIBA 10/2021
1	PPAR alphaIBA 07/2021
1	Fenofibrate (CiL)FDA LinkGeneric 07/2021
1	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	NivolumabIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2018
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2017
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	CCAAT-Enhancer-Binding ProteinsIBA 11/2017
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 11/2017
1	Adenosine Monophosphate (AMP)IBA 11/2017
1	Oxygen (Dioxygen)IBA 11/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2016
1	Ethambutol (Myambutol)FDA LinkGeneric 07/2016
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2016
1	FluoroquinolonesIBA 07/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 10/2021 - 03/2013
5	Therapeutics 10/2021 - 04/2013
2	Pneumonectomy (Lung Volume Reduction) 03/2004 - 02/2004
1	Glycemic Control 10/2021
1	Humidifiers 10/2021
1	Lasers (Laser) 01/2021
1	Renal Dialysis (Hemodialysis) 01/2019
1	Lung Transplantation 10/2016